Innovation and Value Initiative’s (IVI) Jennifer Bright on Value Assessment and Transparency
Jennifer Bright is Executive Director of the Innovation and Value Initiative (IVI), a non-profit organization whose mission is to to [...]
Drugmakers Hope to Trump International Pricing Plan with Counterproposal
Drugmakers hope to stall Trump’s ‘preferred nations’ directive by making a counteroffer to the White House. The president’s directive aims [...]
Upcoming Academy of Managed Care Pharmacy (AMCP) Webinar: Helping Patients Anticipate and Manage Drug Costs
Join Joe Honcz, RPh, MBA, Principal C4i and Kollet Koulianos, MBA, Senior Director Payer Relations, National Hemophilia Foundation (NHF) on [...]
Social Determinants of Health Used in Redesign of Referral Networks
Experts call for payers to work alongside community-based organizations to strengthen referral networks. Blue KC heeded the call and found [...]
Policy Changes to Health Technology Assessment Process Reshape Market Access in South Korea
South Korea’s healthcare landscape has been constantly evolving since the passage of important legislation 20 years ago. However, concern remains [...]
What Are The Recent Top 4 Innovative Consolidations and Partnerships Among Health Payers?
Despite the impacts of the coronavirus pandemic, health payers have still managed to initiate innovative consolidations and partnerships. According to [...]
Real World Evidence Poised to Tip the Balance in Fight Against COVID-19 Through Aetion’s Series B Platform
Tech startup Aetion has added US$19 million to their real-world evidence platform Series B, bringing their round to US$82 million. [...]
Nobel Prize-Winning Economist Michael Kremer Assumes Post of University Professor at University of Chicago
On September 1st, nobel Prize-winning economist Michael Kremer will assume the post of University Professor at the University of Chicago, [...]
Politics Trump Drug Prices
President Trump has been campaigning on an executive order to lower prescription drug prices in the US. However, no such [...]
Are Healthcare Prices in the U.S. Too High, Too Low, or Both?
Many households in the US face an enormous burden due to the high cost of healthcare and the lack of [...]
Getting the Most Out of Systematic Literature Reviews With DistillerSR
Chris Waters-Banker, Research Lead for Medlior Health Outcomes Research Ltd., outlines five ways to utilize the filter feature to optimize [...]
Association for Accessible Medicines (AAM) Names Health Care Advocate Dan Leonard President and CEO
Dan Leonard was appointed President and Chief Executive Officer of The Association for Accessible Medicines (AAM) today by the association’s [...]
Aris Angelis and Colleagues Evaluate the Institute for Clinical and Economic Review’s (ICER) 2020 Value Framework Update
Angelis et al. use using multiple criteria decision analysis and decision conferencing to evaluate ICER’s updated value framework. The authors [...]
The Professional Society for Health Economics and Outcomes Research (ISPOR) Announces New COVID-19 Member Community
ISPOR launched its COVID-19 Member Community, a platform where ISPOR members can share ideas, discuss challenges, and post questions related [...]
Medical Device Innovation Consortium’s (MDIC) Real-World Evidence Framework for In Vitro Diagnostics Takes Aim at COVID-19
The Medical Device Innovation Consortium (MDIC) finished developing its Real-World Evidence (RWE) Framework for regulatory decision-making for in vitro diagnostics [...]
The European Medicines Agency (EMA) Seeks to Develop Sentinel-Style RWD Database
The European Medicines Agency is soliciting input from organizations interested in developing, operating, and maintaining a healthcare data analysis platform [...]
How is the Institute for Clinical and Economic Review (ICER) Incorporating the Patient’s Voice in Value Assessments?
Evaluating the cost-effectiveness of interventions with value assessment frameworks continues to gain traction in US healthcare. Now attention is shifting [...]
New Research Agenda Seeks to Usher in New Era of Patient-centered Personalized Medicine.
The Personalized Medicine Coalition (PMC) released a new patient-centered research agenda for personalized medicine defining 45 research questions across nine [...]
Employers, Insurers Unnerved by Rising Virtual Doctor Visit Rates
Employers fear higher rates for telehealth will eliminate savings. However, a shift in provider reimbursement may ultimately help lower costs [...]
How is Real-World Data Leveraged to Improve Outcomes in the Context of COVID-19?
In this time of crisis brought on by the COVID-19 pandemic, researchers and leaders have to look beyond time-intensive, expensive [...]
Study Finds Cost-sharing Assistance Programs Can Save Patients Thousands While Leading to Improved Adherence and Health Outcomes.
According to a recent analysis by IQVIA, chronically ill patients using cost-sharing assistance saved hundreds to thousands of dollars on [...]
How Can Excessive Price Increases Be Better Regulated?
Much of the overall spending on prescription drugs in the United States can be attributed to price increases, resulting in [...]
What is the Most Effective Way to Navigate Pricing Models for COVID-19 Innovations?
Preliminary clinical benefit information is translated into longer-term health benefit and economic value through pricing models, making them invaluable for [...]
Value of a QALY for France
Until now, no cost-effectiveness threshold (CET) has been officially proposed in France to qualify incremental cost-effectiveness ratios (ICERs). To address [...]
How Did Pharmaceutical Policy Reform Change the Healthcare Landscape in China?
China’s pharmaceutical market is second only to the United States valued at $137 billion (USD). Fueling Growth has been fueled [...]